European Journal of Clinical Investigation

Update on endothelin-related diseases
pp. 1-2(2)
Authors: Pittrow, D.; Kirch, W.

Endothelin receptor antagonists in preclinical models of pulmonary hypertension
pp. 3-13(11)
Authors: Pullamsetti, S. S.; Schermuly, R. T.

Interaction of acenocoumarol and sitaxentan in pulmonary arterial hypertension
pp. 14-18(5)
Authors: Pulido, T.; Sandoval, J.; Roquet, I.; Gutiérrez, R.; Rueda, T.; Peña, H.; Santos, E.; Miranda, M. T.; Lupi, E.

Endothelin receptor selectivity: evidence from in vitro and pre-clinical models of scleroderma
pp. 19-26(8)
Authors: Shiwen, X.; Leask, A.; Abraham, D. J.; Fonseca, C.

A review of STRIDE-2 and STRIDE-2X: the case for selective endothelin receptor blockade
pp. 27-31(5)
Authors: Langleben, D.; Cacoub, P.

Endothelin receptor selectivity in chronic renal failure
pp. 32-37(6)
Authors: Longaretti, L.; Benigni, A.

The science of endothelin-1 and endothelin receptor antagonists in the management of pulmonary arterial hypertension: current understanding and future studies
pp. 38-49(12)
Authors: Davie, N. J.; Schermuly, R. T.; Weissmann, N.; Grimminger, F.; Ghofrani, H. A.

Endothelin receptor selectivity in chronic kidney disease: rationale and review of recent evidence
pp. 50-67(18)
Authors: Neuhofer, W.; Pittrow, D.

Bleeding events in pulmonary arterial hypertension
pp. 68-73(6)
Authors: Opitz, C. F.; Kirch, W.; Mueller, E. A.; Pittrow, D.

Endothelin receptor antagonism and cancer
pp. 74-77(4)
Authors: Bhalla, A.; Haque, S.; Taylor, I.; Winslet, M.; Loizidou, M.

Endothelin-1 and vein graft occlusion in patients undergoing bypass surgery
pp. 78-87(10)
Author: Dashwood, M. R.